Complications associated with the current sequential pharmacological management of early postnatal hypotension in extremely premature infants

Proceedings
Rita P VermaHegang H Chen

Abstract

Early postnatal hypotension in premature infants is treated with escalating doses of vasopressor-inotropes (VI), followed by hydrocortisone if VI therapy fails. The adverse effects of this standard clinical practice have not been well reported. In a retrospective case-control study, we compared the complications associated with VI and hydrocortisone (HCVI) treatments in extremely low-birth-weight infants (≤1000 g) with contemporaneous normotensive medication-naïve controls via standard univariate and multivariate analyses. Birth weight, gestational age, and receipt of antenatal steroids did not differ between VI (n = 74) and control (n = 124) groups, while the occurrence of gestational diabetes mellitus and risks for patent ductus arteriosus, intraventricular-periventricular hemorrhage, spontaneous intestinal perforation, ventriculomegaly, and bronchopulmonary dsyplasia were higher in VI. Infants in the HCVI group (n = 69) had lower birth weight, gestational age, and receipt of antenatal steroids and higher risks for intraventricular-periventricular hemorrhage, bronchopulmonary dysplasia, air leaks, and patent ductus arteriosus than controls. Whereas the occurrences of spontaneous intestinal perforation, ventriculomegaly, and m...Continue Reading

References

Mar 1, 1976·American Heart Journal·W PawlikE D Jacobson
Jun 1, 1995·American Journal of Obstetrics and Gynecology·S A FriedmanB M Sibai
May 1, 1997·Archives of Disease in Childhood. Fetal and Neonatal Edition·D Bourchier, P J Weston
Aug 15, 2001·Journal of Perinatology : Official Journal of the California Perinatal Association·P V GordonD D Marshall
Sep 6, 2001·Journal of Perinatology : Official Journal of the California Perinatal Association·I Al-AweelD K Richardson
Feb 21, 2002·Developmental Medicine and Child Neurology·Olaf DammannUNKNOWN Developmental Epidemiology Network
Nov 7, 2003·Archives of Disease in Childhood. Fetal and Neonatal Edition·S J Dasgupta, A B Gill
Apr 21, 2006·Journal of Perinatology : Official Journal of the California Perinatal Association·I Seri
Jun 23, 2006·Journal of Perinatology : Official Journal of the California Perinatal Association·L PaquetteI Seri
Jul 4, 2006·Seminars in Perinatology·Avroy A Fanaroff, Jonathan M Fanaroff
Feb 26, 2008·Archives of Disease in Childhood. Fetal and Neonatal Edition·O Khwaja, J J Volpe
Nov 26, 2008·The Journal of Pediatrics·Beau BattonMichele Walsh
Dec 9, 2010·Archives of Disease in Childhood. Fetal and Neonatal Edition·J Wells LoganUNKNOWN ELGAN Study Investigators
Jan 29, 2011·Klinische Pädiatrie·C HünselerT Schaible
Jan 29, 2011·Journal of Perinatology : Official Journal of the California Perinatal Association·J W LoganUNKNOWN ELGAN Study Investigators
Dec 14, 2011·The Cochrane Database of Systematic Reviews·Hafis IbrahimNimish V Subhedar
Feb 4, 2014·The Journal of Pediatrics·Thomas AlderliestenFrank van Bel
Nov 15, 2015·Archives of Disease in Childhood. Fetal and Neonatal Edition·Beau BattonUNKNOWN Eunice Kennedy Shriver National Institute of Child Health & Human Development Neonatal Research Network
May 14, 2016·World Journal of Clinical Pediatrics·Sadaf I BhayatMichael Eisenhut

❮ Previous
Next ❯

Citations

Jan 16, 2021·Italian Journal of Pediatrics·Gianluca TerrinMario De Curtis
Mar 25, 2021·Journal of Perinatology : Official Journal of the California Perinatal Association·Laura E MillerRachel G Greenberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.